The genetic basis and polygenic nature of hair whorl orientation are both shown by the first gene mapping study on human scalp hair whorls. An article in the Elsevier-distributed Journal of Investigative Dermatology reports the discovery of four linked genetic variants that are likely to hav
Parkinson's disease (PD), which affects millions of people worldwide, causes gait irregularities that substantially decrease their quality of life. Despite the availability of several pharmacological, surgical, and rehabilitative treatments, their effectiveness is limited. This limitation ha
Regular behaviours, such as drinking coffee and listening to music, can affect brain activity in ways that improve cognitive function, particularly in tasks requiring focus and memory.
While it is understood that white matter loss in the brain leads to neurological abnormalities, there is currently no treatment available to help these neonates avoid this outcome.
Mayo Clinic and Yale University scientists determined that the origins of autism spectrum disorder may be related to an imbalance of particular neurons that play a vital role in how the brain communicates and works using human "mini-brain" models known as organoids. The cells in question are
The first gene mapping investigation on human scalp hair whorls demonstrates both the genetic foundation and the polygenic nature of hair whorl orientation.
Regular activities like drinking coffee and listening to music can influence a person's brain activity in ways that enhance cognitive function, notably in tasks requiring focus and memory.
Patients with Parkinson's disease (PD), an illness that affects millions of people worldwide, experience gait-related abnormalities that significantly lower their quality of life. Despite the existence of numerous pharmaceutical, surgical, and rehabilitative treatments, their efficacy is con
While it is recognised that white matter loss in the brain would result in neurological deficits, there is currently no medication available to help these newborns prevent this outcome.
A type of monoclonal antibody that has already been tested in cancer may be a viable treatment for amyotrophic lateral sclerosis, or ALS, a fatal neurological disease.
Researchers at the Burke Neurological Institute and Weill Cornell Medicine have completed a preclinical investigation on a non-opioid designer molecule that calms hyperactive pain-sensing neurons in the peripheral nervous system to treat chronic neuropathic pain. The results of the study are
A type of monoclonal antibody that has already been tried in certain types of cancer may be a viable treatment for amyotrophic lateral sclerosis, or ALS, a fatal neurological illness.